Takeda Pharmaceutical (TAK) Revenue Growth (5y) (2022 - 2026)
Takeda Pharmaceutical (TAK) Revenue Growth (5y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.09 Bn | 43.13 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.26 Bn | 39.60 Bn | 2.15 Bn |
| 3 | Zoetis | 31.94 Bn | 30.26 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.74 Bn | 22.95 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.21 Bn | 19.55 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.87 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - |
| 10 | Alkermes | 8.14 Bn | 7.48 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.47% |
| Mar 31, 2026 | 1.34% |
| Dec 31, 2025 | -2.34% |
| Sep 30, 2025 | 26.37% |
| Jun 30, 2025 | 0.51% |
| Mar 31, 2025 | 0.30% |
| Sep 30, 2024 | 25.63% |
| Jun 30, 2024 | 0.10% |
| Mar 31, 2024 | -71.16% |
| Dec 31, 2023 | 9.93% |
| Sep 30, 2023 | -64.36% |
| Jun 30, 2023 | 13.36% |
| Mar 31, 2023 | 16.69% |
| Dec 31, 2022 | 12.42% |